EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Polygenic risk for schizophrenia and bipolar disorder in relation to cardiovascular biomarkers

Elina J Reponen, Thor Ueland, Jaroslav Rokicki, Francesco Bettella, Monica Aas, Maren C F Werner, Ingrid Dieset, Nils E Steen, Ole A Andreassen, Martin Tesli

European Archives of Psychiatry and Clinical Neuroscience · 2024

DOI: 10.1007/s00406-023-01591-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Archives of Psychiatry and Clinical Neuroscience, 2024. Verfasst von Elina J Reponen und 9 weiteren Autor:innen. Beteiligte Einrichtung: NORMENT, Norwegian Centre for Mental Disorders Research, Oslo University Hospital and University of Oslo, Nydalen, P.O. Box 4956, N- 0424, Oslo, Norw…. Hauptthemen laut MEDLINE: Bipolar Disorder, Schizophrenia, Cardiovascular Diseases, Multifactorial Inheritance. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norges Forskningsråd, Helse Sør-Øst RHF, Helse Vest Regionalt Helseføretak.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Individuals with schizophrenia and bipolar disorder are at an increased risk of cardiovascular disease (CVD), and a range of biomarkers related to CVD risk have been found to be abnormal in these patients. Common genetic factors are a putative underlying mechanism, alongside lifestyle factors and antipsychotic medication. However, the extent to which the altered CVD biomarkers are related to genetic factors involved in schizophrenia and bipolar disorder is unknown. In a sample including 699 patients with schizophrenia, 391 with bipolar disorder, and 822 healthy controls, we evaluated 8 CVD risk biomarkers, including BMI, and fasting plasma levels of CVD biomarkers from a subsample. Polygenic risk scores (PGRS) were obtained from genome-wide associations studies (GWAS) of schizophrenia and bipolar disorder from the Psychiatric Genomics Consortium. The CVD biomarkers were used as outcome variables in linear regression models including schizophrenia and bipolar disorder PGRS as predictors, age, sex, diagnostic category, batch and 10 principal components as covariates, controlling for multiple testing by Bonferroni correction for the number of independent tests. Bipolar disorder PGRS was significantly ( p = 0.03) negatively associated with BMI after multiple testing correction, and schizophrenia PGRS was nominally negatively associated with BMI. There were no other significant associations between bipolar or schizophrenia PGRS, and other investigated CVD biomarkers. Despite a range of abnormal CVD risk biomarkers in psychotic disorders, we only found a significant negative association between bipolar disorder PGRS and BMI. This has previously been shown for schizophrenia PGRS and BMI, and warrants further exploration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderSchizophreniaCardiovascular DiseasesMultifactorial InheritanceBiomarkersHumansFemaleMaleAdultMiddle AgedGenome-Wide Association StudyBody Mass Index

Stichwörter der Autor:innen

BMIBipolar disorderCardiovascular biomarkersPolygenic riskSchizophrenia

Substanzen

Biomarkers

Autor:innen und Institutionen

  • NORMENT, Norwegian Centre for Mental Disorders Research, Oslo University Hospital and University of Oslo, Nydalen, P.O. Box 4956, N- 0424, Oslo, Norway. e.j.reponen@medisin.uio.no.
  • Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • K.G. Jebsen Thrombosis Research and Expertise Center, University of Tromsø, Tromsø, Norway.
  • NORMENT, Norwegian Centre for Mental Disorders Research, Oslo University Hospital and University of Oslo, Nydalen, P.O. Box 4956, N- 0424, Oslo, Norway.
  • Centre for Research and Education in Forensic Psychiatry, Department of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

Förderung

  • Norges Forskningsråd
  • Helse Sør-Øst RHF
  • Helse Vest Regionalt Helseføretak
  • Stiftelsen Kristian Gerhard Jebsen
  • H2020 European Research Council
  • University of Oslo

Zitieren

APA

Reponen, E. J., Ueland, T., Rokicki, J., Bettella, F., Aas, M., Werner, M. C. F., Dieset, I., Steen, N. E., Andreassen, O. A., & Tesli, M. (2024). Polygenic risk for schizophrenia and bipolar disorder in relation to cardiovascular biomarkers. European Archives of Psychiatry and Clinical Neuroscience. https://doi.org/10.1007/s00406-023-01591-0

Vancouver

Reponen EJ, Ueland T, Rokicki J, Bettella F, Aas M, Werner MCF, et al. Polygenic risk for schizophrenia and bipolar disorder in relation to cardiovascular biomarkers. European Archives of Psychiatry and Clinical Neuroscience. 2024. doi:10.1007/s00406-023-01591-0

BibTeX
@article{Reponen2024,
  author = {Reponen, Elina J and Ueland, Thor and Rokicki, Jaroslav and Bettella, Francesco and Aas, Monica and Werner, Maren C F and Dieset, Ingrid and Steen, Nils E and Andreassen, Ole A and Tesli, Martin},
  title = {Polygenic risk for schizophrenia and bipolar disorder in relation to cardiovascular biomarkers},
  journal = {European Archives of Psychiatry and Clinical Neuroscience},
  year = {2024},
  doi = {10.1007/s00406-023-01591-0}
}
Kostenlos starten →